Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

LeMaitre Vascular Lowers FY2025 GAAP EPS Guidance from $2.15-$2.32 to $2.07-$2.24 vs $2.24 Est; Raises FY2025 Sales Guidance from $235.40M-$242.80M to $242.00M-$249.00M vs $239.26M Est

Author: Benzinga Newsdesk | May 01, 2025 04:14pm
LeMaitre Vascular (NASDAQ:LMAT) lowers FY2025 GAAP EPS guidance from $2.15-$2.32 to $2.07-$2.24 vs $2.24 analyst estimate. Raises FY2025 sales outlook from $235.40 million-$242.80 million to $242.00 million-$249.00 million vs $239.26 million estimate.

Posted In: LMAT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist